The largest database of trusted experimental protocols

Cdk6 cyclin d1

Manufactured by Thermo Fisher Scientific
Sourced in Japan, United States

The CDK6/Cyclin D1 is a laboratory equipment product that serves as a key component in the regulation of cell cycle progression. It functions as a cyclin-dependent kinase that, when complexed with Cyclin D1, plays a crucial role in controlling the G1/S transition of the cell cycle.

Automatically generated - may contain errors

3 protocols using cdk6 cyclin d1

1

CDK6/Cyclin D1 Kinase Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells’ extracts were subjected to immunoprecipitation using the anti-NPM/B23 antibody. Immunocomplexes were washed with WCE buffer and kinase reaction buffer (25 mM Tris (pH 7.5), 5 mM β-glycerophosphate, 2 mM DTT, 0.1 mM Na3VO4, and 10 mM MgCl2). One μg of CDK6/Cyclin D1 (Invitrogen) was added to the immunocomplexes for 1 h at 30 °C. For inhibition studies, immunocomplexes and CDK6/Cyclin D1 were incubated in the presence of 2 μM palbociclib. The degree of phosphorylation was analyzed with both SDS-PAGE and immunoblotting.
+ Open protocol
+ Expand
2

Quantifying Kinase Activity Using Isotope-Labeled Formaldehyde

Check if the same lab product or an alternative is used in the 5 most similar protocols
Titanium dioxide (titania) particle (10 μm diameter) were purchased from GL Sciences (Tokyo, Japan). Thermo-sensitive alkaline phosphatase (TSAP) and modified trypsin were obtained from Promega (Madison, WI). [2H2, 13C]Formaldehyde was purchased from ISOTEC (Miamisburg, OH). Recombinant human protein kinases were from Carna Biosciences (Kobe, Japan), with the exception of KHS1, SGK496, NIK, CDK6/Cyclin D1, CDK9/Cyclin K, ALK1, CDK4/Cyclin D1, BARK1 and MPSK1 (Invitrogen, Carlsbad, CA) and GPRK5, FRAP, DAPK2, PKG1a, STK33, TAO1 and ULT3 (Millipore, Billerica, MA). More details on kinases are shown in Supplementary Table S5 and Supplementary Information. All other reagents were from WAKO Chemicals (Osaka, Japan).
+ Open protocol
+ Expand
3

Kinase Inhibition Assay for CDK4/6

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inhibition of the catalytic activities of protein kinases, CDK4–cyclin D1 and CDK6–cyclin D1 (Invitrogen, Carlsbad, CA, USA), by GLR2007 (Gan & Lee Pharmaceuticals, Beijing, China) and palbociclib (Selleck Chemicals LLC, Houston, TX, USA) was assessed using a LANCE Ultra time-resolved fluorescence resonance energy transfer assay (PerkinElmer Inc., Waltham, MA, USA) according to the manufacturer’s instructions. GLR2007 was tested across a range of concentrations from 0.0017 nM to 100 nM. palbociclib was tested across a range of concentrations from 0.0169 nM to 1000 nM. Results were calculated as half-maximal inhibitory concentration (IC50) and inhibition constant (Ki). IC50 and Ki values were determined using the XLfit 205 model (ID Business Solutions Ltd, Guildford, UK) curve-fitting add-on for Microsoft Excel (Microsoft Corporation, Redmond, WA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!